Explore the challenges faced by Indian pharma in developing rare disease drugs and potential solutions for innovation and cost reduction.

Discover S&P 500 forecasts for 2025-2026, key market risks, and why pharmaceuticals may outperform. Click for more on my view ...

In Company Announcement No. 25 / 2025 dated December 11, 2025, Zealand Pharma announced a share capital increase due to the ...

Pharmaceutical companies have long complained that Europe spends too little on drugs. It took the arrival of Donald Trump — ...

What is known is that PBM companies, in general, have higher profit margins than drug manufacturers. | Opinion ...

See why TG Therapeutics, Inc. earns a Buy rating, with insights on Briumvi's efficacy and market growth in multiple sclerosis ...

Sun Pharmaceutical Industries targets mid- to high-single digit topline growth in FY26, focusing on innovative medicines and ...

Discover how drugs prevent, cure, and alleviate ailments. Learn about over-the-counter vs. prescription drugs and the ...

Nearly nine months ago, SiriusXM Media published results from its annual Pharma Audience Research Study, showing why digital audio should play a bigger role in a pharma marketer’s media mix. A lot has ...

U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs ...

Asahi Kasei Pharma Corporation has announced plans to relocate its R&D hub from Izunokuni City, Shizuoka Prefecture (Ohito) ...